Vicus Capital Sells 5,814 Shares of Colgate-Palmolive Company (NYSE:CL)

Vicus Capital lessened its holdings in Colgate-Palmolive Company (NYSE:CL - Free Report) by 8.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 65,869 shares of the company's stock after selling 5,814 shares during the period. Vicus Capital's holdings in Colgate-Palmolive were worth $6,172,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in the business. Inscription Capital LLC bought a new stake in Colgate-Palmolive in the first quarter valued at $3,269,000. QRG Capital Management Inc. raised its stake in shares of Colgate-Palmolive by 4.9% during the first quarter. QRG Capital Management Inc. now owns 69,037 shares of the company's stock worth $6,469,000 after buying an additional 3,201 shares during the last quarter. Sagespring Wealth Partners LLC boosted its position in shares of Colgate-Palmolive by 10.7% in the 1st quarter. Sagespring Wealth Partners LLC now owns 7,611 shares of the company's stock worth $713,000 after purchasing an additional 737 shares during the last quarter. Adero Partners LLC increased its stake in shares of Colgate-Palmolive by 28.7% in the 1st quarter. Adero Partners LLC now owns 3,871 shares of the company's stock valued at $363,000 after acquiring an additional 864 shares during the last quarter. Finally, Sowell Financial Services LLC acquired a new stake in Colgate-Palmolive in the first quarter worth $501,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Trading Down 0.4%

Shares of Colgate-Palmolive stock traded down $0.34 during trading hours on Friday, hitting $87.85. The company's stock had a trading volume of 9,572,156 shares, compared to its average volume of 4,792,528. The company has a market capitalization of $71.19 billion, a PE ratio of 24.82, a P/E/G ratio of 4.68 and a beta of 0.38. The business has a fifty day moving average of $91.63 and a 200 day moving average of $90.85. Colgate-Palmolive Company has a 1-year low of $85.32 and a 1-year high of $109.30. The company has a quick ratio of 0.54, a current ratio of 0.85 and a debt-to-equity ratio of 8.96.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, April 25th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.86 by $0.05. The company had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.92 billion. Colgate-Palmolive had a return on equity of 461.04% and a net margin of 14.52%. The business's revenue was down 3.0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.86 earnings per share. As a group, equities analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be given a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.37%. The ex-dividend date is Friday, July 18th. Colgate-Palmolive's payout ratio is currently 58.76%.

Colgate-Palmolive announced that its Board of Directors has initiated a stock buyback plan on Thursday, March 20th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the company to reacquire up to 6.8% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's board of directors believes its stock is undervalued.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on CL shares. JPMorgan Chase & Co. increased their price target on Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a research report on Monday, April 28th. Piper Sandler reduced their target price on shares of Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a report on Monday, March 31st. Wells Fargo & Company upped their price target on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an "underweight" rating in a research report on Wednesday, April 2nd. Barclays reduced their price target on shares of Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating for the company in a research report on Friday, April 11th. Finally, Citigroup boosted their target price on Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a research note on Monday, April 28th. One analyst has rated the stock with a sell rating, ten have given a hold rating and ten have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $102.12.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.